{"id":"W4414794257","doi":"10.1080/10428194.2025.2561737","title":"Real-world treatment adherence and persistence of FLT3 inhibitors as post-alloHCT maintenance therapy in patients with AML in the United States: a cohort study using administrative claims data","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; National Center for Advancing Translational Sciences; Astellas Pharma Canada","keywords":"Discontinuation; Midostaurin; Myeloid leukemia; Sorafenib; Hematopoietic cell; Maintenance therapy; Cohort; Transplantation; Persistence (discontinuity)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002374668,0.0003124981,0.0005785945,0.0009985084,0.0005393295,0.001279205,0.0006164367,0.0006349488,0.0008595244],"category_scores_gemma":[0.005950347,0.0004825736,0.001186797,0.002260838,0.0003635811,0.0008641672,0.0009555808,0.001292954,0.0001695921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006890262,"about_ca_system_score_gemma":0.0005991206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01261358,"about_ca_topic_score_gemma":0.01556869,"domain_scores_codex":[0.9975713,0.0008139869,0.0003974644,0.0005727267,0.0003924844,0.0002521042],"domain_scores_gemma":[0.9935819,0.0009066032,0.003870404,0.00069514,0.0004126593,0.0005332793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001262455,0.00004071533,0.9989364,0.000009810954,0.000158456,0.00002440101,0.00006552695,0.00003253684,0.00003470936,0.00001207742,0.0001043634,0.0004549646],"study_design_scores_gemma":[0.00002186382,0.00008824913,0.9986711,0.00001769238,0.00009887431,0.0001371562,0.0002310332,0.0004756855,0.00003079253,0.00002153781,0.0001975067,0.000008561311],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985288,0.0002647247,0.0000513536,0.00006023331,0.000006535194,0.00001006511,0.0009448647,0.000002056013,0.0001312884],"genre_scores_gemma":[0.9987594,0.0001065917,0.000058249,0.00004635351,0.00001179191,0.00001327769,0.0009630931,0.000001898302,0.00003943828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01261358,"threshold_uncertainty_score":0.02508026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0442771537125276,"score_gpt":0.3291058326767186,"score_spread":0.284828678964191,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}